ESC Cardio Talk
Author: European Society of CardiologySubscribed: 80Played: 718
Hear renowned experts discuss cardiovascular advances relevant to daily practice.
Check here regularly to stay up to date.
Journal Editorial - Thromboembolic events around the time of cardioversion for atrial fibrillation.
ESC Congress - Results of the European Infective Endocarditis registry (ESC-EORP EURO-ENDO)
ESC Congress 2019 - Is perivascular fat a new cardiovascular risk factor? Results of SCOT-HEART
ESC Congress 2019 - DANAMI-2 - 16-year follow-up of the Danish Acute Myocardial Infarction 2 trial - Primary percutaneous coronary intervention versus fibrinolysis in ST-elevation myocardial infarction
ESC Congress 2019 - Residual Inflammatory Risk Associated with Interleukin-18 and Interleukin-6
ESC Congress 2019 - The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease, a cohort study
ESC Congress 2019 - Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
ESC Congress 2019 - High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy
ESC Congress 2019 - Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME
Journal Editorial - Defining high bleeding risk in patients undergoing percutaneous coronary intervention